Atrial natriuretic peptide regulates adipose tissue accumulation in adult atria
The abundance of epicardial adipose tissue (EAT) is associated with atrial fibrillation (AF), the most frequent cardiac arrhythmia. However, both the origin and the factors involved in EAT expansion are unknown. Here, we found that adult human atrial epicardial cells were highly adipogenic through a...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 114; no. 5; pp. E771 - E780 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
31.01.2017
|
Series | PNAS Plus |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The abundance of epicardial adipose tissue (EAT) is associated with atrial fibrillation (AF), the most frequent cardiac arrhythmia. However, both the origin and the factors involved in EAT expansion are unknown. Here, we found that adult human atrial epicardial cells were highly adipogenic through an epithelial–mesenchymal transition both in vitro and in vivo. In a genetic lineage tracing the WT1CreERT2+/−RosatdT+/− mouse model subjected to a high-fat diet, adipocytes of atrial EAT derived from a subset of epicardial progenitors. Atrial myocardium secretome induces the adipogenic differentiation of adult mesenchymal epicardium-derived cells by modulating the balance between mesenchymal Wingless-type Mouse Mammary Tumor Virus integration site family, member 10B (Wnt10b)/β-catenin and adipogenic ERK/MAPK signaling pathways. The adipogenic property of the atrial secretome was enhanced in AF patients. The atrial natriuretic peptide secreted by atrial myocytes is a major adipogenic factor operating at a low concentration by binding to its natriuretic peptide receptor A (NPRA) receptor and, in turn, by activating a cGMP-dependent pathway. Hence, our data indicate cross-talk between EAT expansion and mechanical function of the atrial myocardium. |
---|---|
Bibliography: | PMCID: PMC5293064 Edited by Christine E. Seidman, Howard Hughes Medical Institute, Harvard Medical School, Boston, MA, and approved December 13, 2016 (received for review July 6, 2016) Author contributions: N.S., T.M.-M., I.D., M.P., and S.N.H. designed research; N.S., T.M.-M., P.F., C.R.-M., G. Dilanian, M.F., and D.S. performed research; N.S. and T.M.-M. contributed new reagents/analytic tools; N.S., T.M.-M., P.F., C.R.-M., G. Dilanian, M.F., D.S., G. Derumeaux, P.L., K.C., I.D., M.P., and S.N.H. analyzed data; and N.S., T.M.-M., G. Derumeaux, P.L., I.D., M.P., and S.N.H. wrote the paper. |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.1610968114 |